Study for the clinical effect evaluation of strengthening spleen and lowering the stomach Qi therapy for reflux esophagitis with spleen deficiency
- Conditions
- reflux esophagitis
- Registration Number
- ITMCTR1900002514
- Lead Sponsor
- Dong Fang Hospital, Beijing University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1) Clinical diagnosis of Western medicine in accordance with reflux esophagitis, endoscopic in accordance with the diagnosis of reflux esophagitis;
2) in line with reflux esophagitis TCM deficiency gas inverse syndrome (spleen deficiency type) diagnosis;
3) Male and female aged 18-65 years old, voluntarily signed the subject's informed consent.
1. Anti-acid and heartburn caused by severe organic lesions and other diseases or drugs;
2. Persons with disabilities under the law (blindness, deafness, mute, intellectual impairment, physical disability);
3. Pregnant or prepared for pregnancy, lactating women;
4. Allergic physique or allergic to research drug ingredients;
5. Suspected or indeed has a history of alcohol and substance abuse;
6. Patients who have participated in other clinical studies within 3 months;
7. Patients who have used the relevant therapeutic drugs within 1 months;
8. Unclear description of self-symptoms or investigation of non-authors;
9. with cardiac achalasia, esophageal fissure hernia, high intestinal obstruction and gastrointestinal surgery history;
10. with tumor, digestive system ulcer and other sexual diseases;
11. with hepatobiliary and pancreatic diseases, pregnancy, connective tissue disease and serious systemic diseases;
12. with circulatory system, nervous system, urinary tract and other serious primary diseases and mental patients;
13. take drugs that can cause anti-acid or heartburn symptoms.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ghrelin;VIP;motilin;
- Secondary Outcome Measures
Name Time Method